Eva Volf

A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.

Eva Volf, Shiu-chung Au, Nicole Dumont et al. · PubMed · 2012 · 88 citations

Prevalence of the Metabolic Syndrome in Children with Psoriatic Disease

Ari M. Goldminz, Catherine D. Buzney, Noori Kim et al. · Pediatric Dermatology · 2013 · 65 citations

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

Shiu‐Chung Au, Ari M. Goldminz, Noori Kim et al. · Journal of Dermatological Treatment · 2012 · 64 citations

Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts.

Eva Volf, Danielle Levine, Melissa Michelon et al. · PubMed · 2011 · 10 citations

Obesity, Metabolic Syndrome, Population Children +15